| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $88M | ||
| $82M |
Buys | $10,943,653 | 2 | 100 |
Sells | $0 | 0 | 0 |
| Ashiya Mona | director | 1 | $5.47M | 0 | $0 | $5.47M |
| ORBIMED ADVISORS LLC | director | 1 | $5.47M | 0 | $0 | $5.47M |
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Over the last 12 months, insiders at Shattuck Labs, Inc. have bought $10.94M and sold $0 worth of Shattuck Labs, Inc. stock.
On average, over the past 5 years, insiders at Shattuck Labs, Inc. have bought $2.87M and sold $8.23M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ashiya Mona (director) — $5.47M. ORBIMED ADVISORS LLC (director) — $5.47M.
The last purchase of 6,306,127 shares for transaction amount of $5.47M was made by Ashiya Mona (director) on 2025‑08‑25.
| 2025-08-25 | ORBIMED ADVISORS LLC | director | 6.31M 11.8986% | $0.87 | $5.47M | +161.15% | ||
| 2025-08-25 | Ashiya Mona | director | 6.31M 11.8986% | $0.87 | $5.47M | +161.15% | ||
| 2024-12-04 | Sale | Redmile Group, LLC | 133,371 0.2728% | $1.25 | $166,714 | -7.20% | ||
| 2024-12-04 | Redmile Group, LLC | 133,371 0.2728% | $1.25 | $166,714 | -7.20% | |||
| 2024-10-07 | Schreiber Taylor | Chief Executive Officer | 36,500 0.0249% | $1.21 | $44,220 | +0.89% | ||
| 2024-06-28 | Brous Tyler | director | 3,000 0.0065% | $3.90 | $11,700 | -68.13% | ||
| 2024-06-27 | Brous Tyler | director | 5,416 0.0117% | $3.89 | $21,068 | -67.20% | ||
| 2024-06-26 | Schreiber Taylor | Chief Executive Officer | 14,400 0.0278% | $3.47 | $50,011 | -67.55% | ||
| 2024-03-06 | Sale | Stout Stephen | See Remarks | 11,354 0.0266% | $10.53 | $119,558 | -63.09% | |
| 2024-01-10 | Sale | Neill Andrew R | Chief Financial Officer | 25,000 0.0527% | $10.00 | $250,000 | -59.86% | |
| 2022-04-26 | Golumbeski George | 28,330 0.0665% | $3.63 | $102,838 | -16.16% | |||
| 2022-04-21 | Golumbeski George | 26,049 0.0621% | $3.69 | $96,121 | -15.89% | |||
| 2022-01-19 | Brous Tyler | director | 3,000 0.0073% | $6.87 | $20,610 | -48.05% | ||
| 2022-01-18 | Brous Tyler | director | 2,500 0.0061% | $7.01 | $17,525 | -48.97% | ||
| 2022-01-14 | Brous Tyler | director | 2,500 0.0058% | $7.16 | $17,900 | -52.05% | ||
| 2021-10-19 | Sale | Thomson Erin Ator | General Counsel | 33,000 0.0774% | $19.50 | $643,500 | -78.12% | |
| 2021-07-15 | Sale | Hornblower Josiah | director | 34 <0.0001% | $22.74 | $773 | -67.34% | |
| 2021-07-15 | Sale | Thomson Erin Ator | General Counsel | 2,000 0.0047% | $22.18 | $44,367 | -67.34% | |
| 2021-07-15 | Sale | Neill Andrew R | Chief Financial Officer | 2,000 0.0047% | $22.13 | $44,263 | -67.34% | |
| 2021-07-14 | Sale | Hornblower Josiah | director | 12,049 0.0289% | $23.14 | $278,784 | -68.01% |
| ORBIMED ADVISORS LLC | director | 5255106 10.9703% | $31.48M | 1 | 0 | |
| Ashiya Mona | director | 5255106 10.9703% | $31.48M | 1 | 0 | |
| Redmile Group, LLC | 5539724 11.5644% | $33.18M | 2 | 1 | +21.24% | |
| Hornblower Josiah | director | 2966709 6.1931% | $17.77M | 0 | 47 | |
| Brous Tyler | director | 238088 0.497% | $1.43M | 5 | 0 | <0.0001% |
| Neill Andrew R | Chief Financial Officer | 173446 0.3621% | $1.04M | 0 | 6 | |
| Stout Stephen | See Remarks | 74437 0.1554% | $445,877.63 | 0 | 1 | |
| Schreiber Taylor | Chief Executive Officer | 71002 0.1482% | $425,301.98 | 2 | 10 | +0.89% |
| Golumbeski George | 54613 0.114% | $327,131.87 | 2 | 0 | <0.0001% | |
| Thomson Erin Ator | General Counsel | 46259 0.0966% | $277,091.41 | 0 | 8 |
$26,922,905 | 100 | 5.55% | $248.34M | |
$8,708,580 | 93 | -5.38% | $239.22M | |
$87,639,490 | 62 | 18.37% | $248.25M | |
$16,169,789 | 40 | 7.44% | $308.08M | |
$64,487,106 | 32 | -22.92% | $294.89M | |
$3,668,031 | 23 | 2.05% | $257.95M | |
$22,365,077 | 19 | -27.47% | $256.39M | |
$245,302 | 15 | -4.08% | $308.71M | |
$10,143,329 | 12 | 11.84% | $294.85M | |
$170,425 | 10 | -16.01% | $237.15M | |
$6,847,110 | 9 | 5.96% | $238.19M | |
$13,043,783 | 8 | 732.82% | $294.57M | |
Shattuck Labs, Inc. (STTK) | $119,804,612 | 8 | -17.22% | $286.94M |
$145,296,407 | 8 | -0.98% | $247.7M | |
$1,346,998 | 7 | 25.06% | $308.4M | |
$17,675,244 | 7 | 92.20% | $300.17M | |
$4,888,000 | 3 | -20.50% | $287.05M | |
$32,289,200 | 3 | -5.46% | $242.8M | |
$37,067 | 3 | -89.81% | $289.07M |
| Increased Positions | 35 | +60.34% | 10M | +28.34% |
| Decreased Positions | 20 | -34.48% | 4M | -11.28% |
| New Positions | 16 | New | 8M | New |
| Sold Out Positions | 5 | Sold Out | 38,603 | Sold Out |
| Total Postitions | 73 | +25.86% | 42M | +17.06% |
| Orbimed Advisors Llc | $23,396.00 | 10.01% | 6.31M | +6M | New | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $23,396.00 | 10.01% | 6.31M | +2M | +34.89% | 2025-09-30 |
| Redmile Group, Llc | $20,552.00 | 8.79% | 5.54M | 0 | 0% | 2025-09-30 |
| Prosight Management, Lp | $20,224.00 | 8.65% | 5.45M | -1M | -17.89% | 2025-09-30 |
| Vanguard Group Inc | $7,896.00 | 3.38% | 2.13M | -19,773 | -0.92% | 2025-09-30 |
| 683 Capital Management, Llc | $5,685.00 | 2.43% | 1.53M | +437,216 | +39.93% | 2025-09-30 |
| Clark Estates Inc/Ny | $5,475.00 | 2.34% | 1.48M | 0 | 0% | 2025-09-30 |
| Pinnacle Associates Ltd | $5,152.00 | 2.2% | 1.39M | +25,000 | +1.83% | 2025-09-30 |
| Bank Of America Corp /De/ | $4,199.00 | 1.8% | 1.13M | +1M | +2,968.2% | 2025-09-30 |
| Millennium Management Llc | $2,563.00 | 1.1% | 690,901 | -152,355 | -18.07% | 2025-09-30 |